KEGG: vg:3077454
Human Cytomegalovirus UL72 is a 46-kDa protein encoded by the UL72 gene of HCMV. Although historically considered to be the equivalent of dUTPase genes found in Alpha- and Gamma-herpesviruses based on sequence homology, experimental evidence demonstrates that the UL72 protein does not possess detectable dUTPase enzymatic activity. The protein is expressed with late kinetics during the viral replication cycle and predominantly localizes to the cytoplasm of infected cells. Despite lacking dUTPase activity, UL72 remains conserved in HCMV, suggesting it may serve alternative functions during viral infection .
The UL72 gene demonstrates late expression kinetics during HCMV infection. RNA analysis and protein detection studies reveal that UL72 transcription and subsequent protein accumulation occur predominantly in the late phase of viral replication. This temporal regulation places UL72 in the category of late viral genes, which typically encode structural proteins or those involved in virion assembly and maturation. The 46-kDa protein product progressively accumulates in the cytoplasm as infection proceeds, with minimal detection during immediate-early and early phases of viral replication .
UL72 is not essential for HCMV replication in human fibroblasts, though it does contribute to optimal viral growth. Experiments with reconstituted HCMV carrying deletions within the UL72 open reading frame (RVDeltaUL72) demonstrate that the virus remains viable but exhibits a moderate growth defect, particularly following low multiplicity of infection (MOI). Importantly, the DNA synthesis profiles of UL72-deleted viruses are not significantly different from those of parental HCMV strains, indicating that UL72 does not play a critical role in viral DNA replication. This non-essential nature contrasts with some other conserved herpesvirus genes and suggests UL72 may provide a selective advantage in specific contexts or cell types not fully captured in standard laboratory conditions .
Despite UL72's classification as a homolog of dUTPase based on sequence analysis, the protein lacks detectable enzymatic activity when expressed recombinantly in E. coli and purified for functional testing. This discrepancy between sequence conservation and functional activity represents an intriguing evolutionary puzzle. Several potential explanations exist: UL72 may have undergone mutations in catalytic residues critical for dUTPase function while maintaining structural similarity; the protein may require specific post-translational modifications absent in recombinant expression systems; or UL72 might have evolved to perform entirely different functions while retaining structural elements of its ancestral dUTPase. Comparative structural analysis of UL72 with functional dUTPases from related viruses would help identify specific alterations that abolished enzymatic activity while potentially conferring new functions .
The lack of dUTPase activity in UL72 raises questions about how HCMV manages dUTP levels during replication, as elevated dUTP can lead to misincorporation into viral DNA and subsequent genome instability. Several potential compensatory mechanisms warrant investigation: HCMV may rely entirely on host cell dUTPase activity; the virus might upregulate host dUTPase expression during infection; HCMV could encode alternative enzymes with dUTP-hydrolyzing capabilities; or the virus may have evolved replication mechanisms less sensitive to dUTP incorporation. Research examining the regulation of host dUTPase during HCMV infection and the sensitivity of viral DNA polymerase to dUTP would provide valuable insights into these potential adaptations .
While UL72 lacks detectable dUTPase activity, reconstituted viruses with UL72 deletions display moderate growth defects, suggesting the protein contributes to viral fitness through alternative mechanisms. Potential functions worth investigating include: protein-protein interactions that regulate viral or cellular processes; involvement in virion assembly or structure; modulation of host immune responses; or regulation of other enzymatic activities within the infected cell. Proteomic approaches to identify UL72 binding partners, combined with detailed phenotypic characterization of UL72-deleted viruses in various cell types and conditions, would help elucidate these potential non-enzymatic functions. The protein may serve as a decoy or regulatory factor rather than an enzyme in the viral life cycle .
Several complementary approaches can be employed to comprehensively investigate UL72 protein interactions within the viral and cellular context. Co-immunoprecipitation (Co-IP) using antibodies against UL72 or potential partner proteins represents a straightforward approach to identify stable interactions. For detection of weaker or transient interactions, proximity-based labeling methods such as BioID or APEX can be more effective, wherein UL72 is fused to a biotin ligase that tags nearby proteins for subsequent purification and identification by mass spectrometry. Yeast two-hybrid screening provides another system for identifying direct protein-protein interactions, though with higher potential for false positives. Additionally, in situ visualization techniques including proximity ligation assays (PLA) or fluorescence resonance energy transfer (FRET) can confirm interactions in their native cellular context. Crosslinking mass spectrometry offers the advantage of mapping specific interaction domains between UL72 and its partners .
Purification of recombinant UL72 to high homogeneity requires a multi-step approach tailored to the protein's biochemical properties. Based on established protocols for similar viral proteins, an effective purification strategy begins with affinity chromatography using the tag incorporated into the recombinant construct (e.g., Ni-NTA for His-tagged UL72). This initial step should be followed by ion exchange chromatography, exploiting UL72's predicted isoelectric point to separate it from contaminants with different charge properties. Size exclusion chromatography serves as an excellent final polishing step, separating monomeric UL72 from aggregates and removing any remaining low-molecular-weight contaminants. Throughout the purification process, buffer optimization is critical - maintaining pH 7.5-8.0 with 150-300 mM NaCl and 5-10% glycerol helps preserve protein stability. Addition of reducing agents such as DTT or β-mercaptoethanol (1-5 mM) can prevent disulfide-mediated aggregation. For applications requiring ultra-high purity, affinity tag removal followed by a second round of chromatography can be implemented .
Designing appropriate controls for UL72 functional studies requires careful consideration of both positive and negative comparisons. When investigating the potential dUTPase activity of UL72, researchers should include a known active viral dUTPase (e.g., from HSV-1 or EBV) as a positive control under identical experimental conditions. Additionally, an enzymatically inactive mutant of the same dUTPase (with mutations in catalytic residues) provides a valuable negative control. For studies examining phenotypic effects of UL72 deletion, the experimental design should include: the wild-type parental virus, the UL72-deleted virus, and a rescue virus where UL72 expression has been restored. This three-way comparison differentiates effects specifically attributable to UL72 from potential off-target effects of genetic manipulation. When examining UL72 localization or interaction studies, parallel experiments with unrelated viral proteins expressed with similar kinetics help distinguish specific from non-specific findings .
When faced with contradictory findings regarding UL72 function across different studies, a systematic approach to resolution involves several key strategies. First, detailed comparison of experimental methodologies can identify critical differences in expression systems, purification protocols, or activity assays that might explain discrepancies. Second, researchers should consider strain-specific variations in UL72 sequence or expression, particularly when different laboratory-adapted or clinical HCMV isolates are used. Third, implementation of multiple, orthogonal techniques to measure the same functional outcome provides stronger evidence than reliance on a single assay type. Fourth, collaborative cross-validation between independent laboratories can eliminate lab-specific artifacts. Finally, consideration of threshold sensitivity in enzymatic assays is essential - apparent contradictions regarding dUTPase activity might reflect differences in detection limits rather than true functional disparities. Documentation of all experimental variables, including passage number of viral stocks and cells, is critical for meaningful comparison across studies .
Research comparing UL72 with other HCMV proteins reveals its unique characteristics within the viral genome. While UL72 is expressed with late kinetics, other HCMV proteins like pUL69, pUL76, and pp71 demonstrate immediate-early expression patterns, suggesting fundamentally different roles in the viral replication cycle. UL72's cytoplasmic localization also contrasts with nuclear-targeted proteins like pUL69, which mediates mRNA nuclear export and transactivates certain genes. Furthermore, unlike proteins such as pUL71 (which contributes to secondary envelopment) or pUL77 (which binds to dsDNA and terminase subunits), UL72 has no clearly defined functional role beyond its structural similarity to dUTPase enzymes. This comparative analysis highlights the specialization of viral proteins for distinct functions throughout the replication cycle and underscores the enigmatic nature of UL72 despite its conservation .
High-resolution structural characterization of UL72 represents a critical research priority for understanding its evolutionary relationship to functional dUTPases and potential alternative functions. X-ray crystallography or cryo-electron microscopy of purified recombinant UL72 would reveal the protein's three-dimensional structure, allowing direct comparison with known dUTPase enzymes. Specific focus should be placed on the active site region to identify structural alterations that abolished enzymatic activity while potentially creating new functional surfaces. Hydrogen-deuterium exchange mass spectrometry (HDX-MS) could complement static structural approaches by identifying flexible regions that might participate in protein-protein interactions. Additionally, structural studies of UL72 in complex with potential binding partners would provide crucial insights into its functional interactions. Nuclear magnetic resonance (NMR) spectroscopy of isotopically labeled UL72 could further characterize dynamic regions and potential ligand-binding sites that might be missed in static structural approaches .
Modern genomic and transcriptomic approaches offer powerful tools to advance understanding of UL72 function within the broader context of HCMV infection. CRISPR-Cas9 screening of host factors could identify cellular proteins that synthetically interact with UL72, revealing functional pathways dependent on or regulated by this viral protein. Single-cell RNA sequencing of infected versus uninfected cells, comparing wild-type and UL72-deleted viruses, would provide insights into cell-type specific responses and potentially identify transcriptional networks influenced by UL72. Chromatin immunoprecipitation sequencing (ChIP-seq) could detect any DNA-binding activity of UL72, which might represent an alternative function to dUTPase activity. Ribosome profiling might reveal translational impacts of UL72 expression on viral or host mRNAs. Finally, comparative genomics across clinical HCMV isolates could identify natural variants of UL72 with potential functional consequences, informing structure-function relationships and evolutionary constraints on this enigmatic protein .